Aplagon Oy
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Aplagon Oy
RECRUITINGPhase 2NCT07352800
Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic...
The goal of this study is to learn if a new medicine (called antiplatelet and anticoagulant \[APAC\]) can help the body to prevent blood clots and whether APAC is safe and well...
Sponsor: Aplagon OyEnrolling: 423 locations
Peripheral Arterial Occlusive DiseaseChronic Limb-Threatening Ischemia
RECRUITINGEarly Phase 1NCT06204237
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers...
The goal of this Phase 0 clinical trial is to evaluate safety and biodistribution of \[89Zr\]Zr-DFO-APAC in patients with peripheral arterial occlusive disease / critical limb...
Sponsor: Aplagon OyEnrolling: 101 location
Peripheral Arterial Occlusive DiseaseCritical Limb Ischemia